Key result
During a medium-term follow-up of 3.46 years after valve surgery for rheumatic heart disease, the main complications were atrial fibrillation (18.5%), pulmonary hypertension (12.9%), and death (5.5%).
Why the study?
The study was conducted to show the mid-term complications occurring in patients operated for rheumatic heart disease in Sudan and followed by local cardiologists in Burundi.
Observational (n=54)
In a Burundian cohort undergoing valve surgery for rheumatic heart disease, medium-term complications remain significant, highlighting the need for ongoing specialized follow-up.
Highlights persistent post-operative risks in RHD; leaves open optimal follow-up strategies in similar low-resource cohorts.
Objective: shows the mid-term complications occurring in patients operated in Sudan followed by local cardiologists. Patients and methods: All patients who underwent valve heart surgery abroad for rheumatic heart disease and followed in BURUNDI were included in our study. Results: Middle age= 24, 72 ±11.8 years. There were many woman in our study (61.1%). Mitral valve surgery was the most performed (92.6%). The main medium-term complications were, atrial fibrillation (18.5%), pulmonary hypertension (12.9%) and death (5.5%). Conclusion: Atrial fibrillation, pulmonary hypertension and death were the main complications that occurred in our patients during the medium-term follow-up.
No takes yet. Share an insight, caveat, or question.
Nijimbere et al. (2022) conducted an observational in Rheumatic heart disease (n=54). Valve surgery was evaluated on Medium-term complications. During a medium-term follow-up of 3.46 years after valve surgery for rheumatic heart disease, the main complications were atrial fibrillation (18.5%), pulmonary hypertension (12.9%), and death (5.5%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: